[1] Bonnon C, Atanasoski S. c-Ski in health and disease [J]. Cell Tissue Res, 2012, 347(1): 51-64. [2] 周开升,朱彦东,张海鸿,等. Ski在神经系统中的作用及机制的研究进展[J]. 中国康复理论与实践, 2016, 22(7): 797-800. [3] Pekny M, Wilhelmsson U, Pekna M. The dual role of astrocyte activation and reactive gliosis [J]. Neurosci Lett, 2014, 565: 30-38. [4] Donnelly DJ, Popovich PG. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury [J]. Exp Neurol, 2008, 209(2): 378-388. [5] Lukovic D, Stojkovic M, Moreno-Manzano V, et al. Concise review: reactive astrocytes and stem cells in spinal cord injury: good guys or bad guys? [J]. Stem Cells, 2015, 33(4): 1036-1041. [6] Fernandez AM, Fernandez S, Carrero P, et al. Calcineurin in reactive astrocytes plays a key role in the interplay between proinflammatory and anti-inflammatory signals [J]. J Neurosci, 2007, 27(33): 8745-8756. [7] de Rivero Vaccari JP, Lotocki G, Marcillo AE, et al. A molecular platform in neurons regulates inflammation after spinal cord injury [J]. J Neurosci, 2008, 28(13): 3404-3414. [8] Zhu P, Li JX, Fujino M, et al. Development and treatments of inflammatory cells and cytokines in spinal cord ischemia-reperfusion injury [J]. Mediators Inflamm, 2013, 2013: 701970. [9] Li P, Liu P, Xiong RP, et al. Ski, a modulator of wound healing and scar formation in the rat skin and rabbit ear [J]. J Pathol, 2011, 223(5): 659-671. [10] Catorce MN, Gevorkian G. LPS-induced murine neuroinflammation model: main features and suitability for pre-clinical assessment of nutraceuticals [J]. Curr Neuropharmacol, 2016, 14(2): 155-164. [11] Ahuja CS, Fehlings M. Concise review: bridging the gap: novel neuroregenerative and neuroprotective strategies in spinal cord injury [J]. Stem Cells Transl Med, 2016, 5(7): 914-924. [12] Oyinbo CA. Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade [J]. Acta Neurobiol Exp (Wars), 2011, 71(2): 281-299. [13] Stenudd M, Sabelström H, Frisén J. Role of endogenous neural stem cells in spinal cord injury and repair [J]. JAMA Neurol, 2015, 72(2): 235-237. [14] Allison DJ, Ditor DS. Immune dysfunction and chronic inflammation following spinal cord injury [J]. Spinal Cord, 2015, 53(1): 14-18. [15] Leal-Filho MB. Spinal cord injury: from inflammation to glial scar [J]. Surg Neurol Int, 2011, 2: 112. [16] Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence [J]. Nat Rev Immunol, 2007, 7(3): 179-190. [17] Zhang X, Wang J, Qian W, et al. Dexmedetomidine inhibits tumor necrosis factor-alpha and interleukin 6 in lipopolysaccharide-stimulated astrocytes by suppression of c-Jun N-terminal kinases [J]. Inflammation, 2014, 37(3): 942-949. [18] Heiman A, Pallottie A, Heary RF, et al. Toll-like receptors in central nervous system injury and disease: a focus on the spinal cord [J]. Brain Behav Immun, 2014, 42: 232-245. [19] Dong Y, Benveniste EN. Immune function of astrocytes [J]. Glia, 2001, 36(2): 180-190. [20] Biesmans S, Acton PD, Cotto C, et al. Effect of stress and peripheral immune activation on astrocyte activation in transgenic bioluminescent Gfap-luc mice [J]. Glia, 2015, 63(7): 1126-1137. [21] Biesmans S, Meert TF, Bouwknecht JA, et al. Systemic immune activation leads to neuroinflammation and sickness behavior in mice [J]. Mediators Inflamm, 2013, 2013: 271359. [22] Deheuninck J, Luo K. Ski and SnoN, potent negative regulators of TGF-beta signaling [J]. Cell Res, 2009, 19(1): 47-57. [23] Boche D, Cunningham C, Docagne F, et al. TGFbeta1 regulates the inflammatory response during chronic neurodegeneration [J]. Neurobiol Dis, 2006, 22(3): 638-650. [24] Zhou K, Nan W, Feng D, et al. Spatiotemporal expression of Ski after rat spinal cord injury [J]. Neuroreport, 2017, 28(3): 149-157. [25] Ikeshima-Kataoka H. Neuroimmunological implications of AQP4 in astrocytes [J]. Int J Mol Sci, 2016, 17(8): E1306. [26] Middeldorp J, Hol EM. GFAP in health and disease [J]. Prog Neurobiol, 2011, 93(3): 421-443. |